The qPCR and Digital Pathology Congress, Microfluidics Congress and Synthetic Biology Congress are co-located. Over 500 people will be attending. See who is coming here.

The 2nd Biologics Congress will take place in Germany on 1st & 2nd February 2016. Martin Steegmaier, Head of Discovery, Large Molecule Research, Roche Pharma Research and Early Development, Roche Innovation Center Penzberg will make a Keynote Address on Designing and discovering transformative antibody therapeutics at Roche. Rene Hoet, Head Antibody Lead Discovery, Bayer Healthcare will make a Keynote Address on Novel strategies for antibody discovery and optimization.

We are delighted that the 2nd Digital Pathology Congress already has over 175 attendees! Remind yourself about what was discussed in the first meeting with this full length video from the December 2014 meeting.



We are delighted to announce that Xavier Duportet, young entrepreneur, co-founder and CEO of Eligo Bioscience, who recently announced that they have secured funding of $2.2 million (€2 million) through seed financing from Seventure Partners, will address the 2nd annual Synthetic Biology Congress.

Nickolas Papadopoulos, Professor of Oncology & Director of Translational Genetics, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, USA, will also address the 3rd annual qPCR & digital PCR congress with the first day keynote presentation “Detection of Rare Mutations in Biological Fluids in the Management of Cancer” in which he will not only present data on different applications of liquid biopsy but also on the detection of somatic mutations in other biological fluids and their clinical applications.

At the Microfluidics Congress, Charles Henry, Professor, Department of Chemistry, Colorado State University, USA, will also give the first keynote address “Electrochemical Paper-Based Analytical Devices for Clinical and Environmental Diagnostics”. His talk will focus on recent developments from the Henry laboratory using electrochemical paper-based analytical devices.

The 3rd annual qPCR & digital PCR, Microfluidics and 2nd annual Synthetic Biology Congress will be co-hosted in London on the 20th and 21st of October, 2015.



Don’t miss TATAA’s two-day satellite course on the MIQE guidelines at the qPCR & Digital PCR Congress, which takes place on the 25th and 26th of June in San Diego, USA. The workshop has been specially designed for all those working with qPCR and will provide you with all the tools & strategies to ensure that you have total control of the quality in all the steps of the analysis procedure.

“It’s a well-organized and well attended conference.  There is a lot of buzz and people are very interested in the discussions.” – Professor Stephen Bustin, Professor of Molecular Medicine, Anglia Ruskin University.

Also taking place this June is the Digital Pathology Congress. This event is the sister meeting to the successful European meeting which took place in December 2014 in London attracting over 260 delegates and 25+ exhibitor companies. It is due to take place in San Diego, USA on the 25th and 26th.



Ruth Ley, Associate Professor, Department of Microbiology, Cornell University, will be in London on 7th & 8th May 2015 at the 2nd Microbiome R&D and Business Collaboration Forum: Europe.  She will be exploring How Host Genetics Modulate the Gut Microbiome to Impact Phenotype.

Over 200 people are already booked to attend the 3rd Plant Genomics Congress in London on 11th & 12th May.  We expect to sell out

The U.S. Food and Drug Administration has confirmed that E. Scott Stibitz, Chief, Laboratory of Enteric and Sexually Transmitted Diseases, CBER, U.S. Food and Drug Administration, will give the opening keynote address at the 3rd Microbiome R&D and Business Collaboration Forum: USA.



Read our latest Newsletters;
• Plant Genomics
• Microbiome
• Digital Pathology
• qPCR and Digital PCR

The 2nd Plant Genomics Congress: Asia  will be held in Kuala Lumpur on 19th & 20th March. Platinum Sponsor: FEI Life Sciences. Gold Sponsor: Keygene.

This February the first Biologics Congress  will be held in Germany. The meeting has nearly sold out with 5 places remaining.



The first Digital Pathology Congress took place in London and sold out. Keith Kaplan, who chaired a panel discussion and Editor of the Digital Pathology Blog, said that it was “the best meeting yet.” You can discover more about our US meeting at

We also held our first Microbiome Asia meeting in January, where once again the scientific content of the presentations was highly praised. There is still time to get our free report on the future direction of Microbiome research. Just follow this link: Find out more about our London meeting.



The qPCR & Digital PCR Congress October 2014 SOLD OUT
Tataa:  MIQE Guidelines workshop limited availability.
The Synthetic Biology Congress October 2014 SOLD OUT

Plant Genomics Congress USA
Read this blog on the meeting by DNA Nexus
“The recent St Louis meeting  I thought was excellent.”   Speaker
“Wanted to say I very much enjoyed the St. Louis PGC.  Very effective speakers presenting interesting work, with a greater willingness to show works-in-progress and pose open questions than is typical” Delegate

Get ready for 2015
If you are a sponsor or a delegate then you will want to know that Global Engage’s 2015 calendar of events has been published. In 2014 two of our events sold out and many of our events nearly reached the venue’s capacity. So please make your plans early to avoid disappointment!

The Plant Genomics Congress and the Microbiome Forum will be held in Asia, Europe and the USA. While the Digital Pathology Congress and qPCR and Digital PCR Congress (which sold out this year) will be held once again in London and for the first time in the US. Go to the events page for our full line-up which also includes Biologics, Precision Medicine and Synthetic Biology.



Jo Martin, National Clinical Director of Pathology, NHS England and David Snead, Consultant Histopathologist and Clinical Service Lead, Coventry and Warwickshire Pathology Services, are confirmed speakers at the Digital Pathology Congress. You will be able to get clear insight into the strategy the NHS is pursuing as well a detailed firsthand account of the experiences and lessons learned from implementing that strategy.

Is your Orphan Drug Strategy Future Proofed?  Find out at The Orphan Drugs, Collaborations and Market Access Congress where we answer these questions – Is your Orphan Drugs strategy ready for future market changes?  Do you know how others manage the ethical issues and reputational risks arising from market access and pricing strategies?  Do you know which financing and funding strategies are being recommended now, to effectively balance risks and rewards?

Sarkis K. Mazmanian, PhD. California Institute of Technology will describe a desperately needed therapeutic based on novel immunomodulatory mechanisms evolved by the microbiota in his talk on Mechanisms of Colonization by the Gut Microbiome during Health and Disease at the Microbiome/Microbiota R&D and Business Collaborations Forum



The Mirobiome/Microbiota R&D and Business Collaboration Forum was an outstanding meeting. Watch the highlights on YouTube you can see people are already looking forward to the San Diego meeting later this year!

The Plant Genomics Newsletter is out now. Discover some of the great research being published including Mark Earl Sorrells’ recently co-authored research on the Optimal Design of Preliminary Yield Trials with Genome-Wide Markers. He is speaking at the Plant Genomics Congress in the St Louis, Missouri, 11 & 12 September.



The Microbiome is certainly a hot topic and attracting a great deal of VC interest. Have a look at Microbiome News (below) to learn about some of the research being discussed at this month’s Microbiome/Microbiota R&D and Business Collaboration Forum

Read our four new Newsletters:

Microbiome News

Plant Genomics News

Orphan Drugs News

Synthetic Biology News

Global Synthetic Biology Market Expected to Reach USD13.4 Billion in 2019! And Europe is expected to be the largest driver in the development of this field. The Synthetic Biology Congress  will be opened by a keynote address from Paul Freemont, co-founder and co-director of the EPSRC Centre for Synthetic Biology and Innovation, Imperial College, UK. Imperial College just received a £2m grant for a new research and training facility. Commenting on the award Professor Freemont said: “The new DNA Synthesis and Construction Foundry will streamline and automate the ‘writing’ of DNA at an industrial scale so that tens of thousands of designed DNA constructions can be built and tested. We ultimately want this to become as straightforward as it might be to design a prototype new part for a car”



Global Clinical Trial Outsourcing takes place in just a few weeks. The last few places remain. Find out more at

The Plant Genomics Congress takes place in London on 12 & 13 May. With nearly 250 attendees this meeting will sell out. To register now visit

New qPCR and dPCR Congress Speakers! Stephen Bustin, Professor of Allied Health and Medicine, Anglia Ruskin University, UK and Jim Huggett, Science Leader, Nucleic Acid Metrology, Molecular & Cell Biology, LGC Genomics, UK. Also returning to address the congress are Anders Ståhlberg, Senior Scientist, Department of Pathology, University of Gothenburg, Sweden  and Jan Ruijter, Principle Investigator, Department of Anatomy, Embryology & Physiology, Academic Medical Centre, Amsterdam University, The Netherlands  Full details coming soon:



The Plant Genomics Congress Asia takes place this month. 250 Plant Scientist from across Asia will be gathering in Kuala Lumpur, Malaysia.  Only a few places are left.  Don’t miss out:


Sven Pettersson, Professor at the Karolinska Institute, Sweden & Visiting Professor at the School of Medicine NTU, Singapore is making an opening Keynote Address on day two of the Microbiome/Microbiota R&D and Business Collaboration Forum being held in London on 28 & 29 April, 2014. He will speak about the role of gut microbes in delivering sustained health & review the facts & the visions that lie behind the current research into the microbiome/microbiota.


The Future is Here!

Across Europe governments are facing complex challenges as they prepare to incorporate the potential of personalised medicine into their existing health care systems at a time significant change. For example the decision of the UK government to sequence the genome of 100,000 NHS patients by 2017; the recent work of Japanese Scientists on “Stimulus-triggered fate conversion of somatic cells into pluripotency” and the purported arrival of the $1000 genome, all point to the imminent arrival of truly personalised medicine! It is against this background of advances that The Precision Medicine Congress takes place. It will examine not only the very latest research and developments in this field, but also the emerging challenges facing its implementation as it becomes more established.



The Malaysian Biotechnology Corporation is the Co-Host and Main Sponsor of the Plant Genomics Congress: Asia.

BiotechCorp is the lead development agency for the biotech industry in Malaysia. Since its establishment in 2005, BiotechCorp has played a key role in building the biotech industry in Malaysia. To date, BiotechCorp has facilitated the development of 229 BioNexus-status companies in Malaysia with total approved investment of RM 3.31 billion. BioNexus Status companies are international and Malaysian biotech companies that qualify for fiscal incentives, grants and guarantees administered by BiotechCorp.

The 3rd Global Clinical Trials Outsourcing Congress agenda has been published. Places are strictly limited for this popular Asian meeting held in Seoul, South Korea. Make sure you register early.



High Praise for the First Microbiome Forum:

“cutting edge work presented” Associate Professor, University of Washington
“high-level audience and presenters – mix of industry, biotech & academic representation. Excellent networking” CEO, Enterome
“very relevant talks” Scientific Director, Janssen
“the new science…. excellent speakers” Executive Director, Medical Scientific Leader, Novartis

Come to the meeting in Europe in 2014


Out Now! The Global Engage 2014 Calendar is now online. Plan your training & sponsorship for 2014 with us.

Announcing the Precision Medicine Congress.    Precision Medicine is using the fantastic developments in technology, genetics and biomedical research to understand the causes of disease in order to create precisely focussed therapies that can both predict and prevent illness. Before long it will be routine for every patient’s genome to be sequenced in order to deliver precision treatments based on the special and unique characteristics of the patient’s genes. 20 speakers are confirmed, including Morten Sogaard, Executive Director and Head, Biotechnology & Precision Medicine External R&D Innovation, Pfizer.


Plant Genomics Asia Congress – so for 500 people from across the world have come to the Plant Genomics Congress series held in Europe and America. Join the Asian meeting a be part of a global network of Plant and NGS Scientists. Join our linked in group –

The 3rd Global Clinical Trials Congress – new agenda for 2014 has been published



The 3rd Asia Pharma R&D Outsourcing Congress will take place in San Diego on 21-22 November. Sign up for the event newsletter here.

Mark Adams, Ph.D., Scientific Director, J. Craig Venter Institute, San Diego and Sarkis K. Mazmanian, Professor of Biology, California Institute of Technology will deliver the keynote addresses at the Microbiome/Microbiota R&D and Business Collaboration Forum.  Visit

Get a FREE white paper: “Use of RealTime StatMiner® in cardiac gene expression studies” by the Institute of Cardiovascular Sciences, University of Manchester. StatMiner® is part of the bioinformatics software solutions for data management and data analysis offered by Integromics – sponsors of  the qPCR and Digital PCR Congress.



Roche Join us as Gold Sponsors of the qPCR and Digital PCR Congress meeting in Lyon, France this September

As part of the Genomic and Biologic series of events Global Engage launch the Oligonucleotide & Peptide Based Therapeutics Congress, which will be held on November 18 19 in San Diego, CA, USA. The Oligonucleotide and Peptide Therapeutic market is growing rapidly. Find out more…

Coming soon the agenda for a cutting edge meeting for biotech and venture capital – Microbiome / Microbiota R&D and Business Collaboration Forum, taking place October 7-8, San Diego. Watch this space for updates



Global Engage TV on YouTube features highlights from the sell out Plant Genomics Congress. Watch it here

With a world class panel of speakers, the qPCR and Digital PCR Congress will also feature a Keynote Address by Keith Jerome, Professor and Head, Virology Division, Department of Laboratory Medicine, University of Washington, Associate Member, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, USA.

Plant Genomics USA gets of to a flying start with nearly 40 confirmed speakers.



The first Plant Genomics Congress SOLD OUT



The Global Engage London Plant Genomics Congress has over 200 participants and will sell out shortly. We will be closing it to new registrants later this month. The USA Plant Genomics Congress is now taking bookings.

PRA International is hosting a half-day Workshop: A Step by Step Approach to Globalize your Biosimilars Product at the 2nd Global Clinical Trials Summit in Seoul, South Korea.

The first Global Engage qPCR and Digital PCR Congress will take place in Lyon, France this September. Uniquely the Congress will feature an international speaker panel drawn equally from academia and industry and will provide you with the widest possible range of views on qPCR research and also on the developments in Digital PCR, as this new technology becomes more widespread.



The KHIDI (Korean Health Industry Development Institute) is supporting The 2nd Global Clinical Trials Outsourcing Summit. The summit now also includes a half-day workshop on how to globalize your biosimilars product. The workshop is led by PRA International.



The 1st Plant Genomics Congress is selling out. With ¾ of the venue capacity taken this extremely topical event has been a hit with the academic and commercial plant science and NGS community.



Seoul, South Korea, will host the Global Clinical Trials Outsourcing Summit. Joesph Scheeren, Senior VP, Head of Global Regulatory Affairs & Global Development Asia, Bayer will deliver the opening keynote address. There has been a high delegate take up from China and Asia ahead of the Chinese New Year!